These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19890998)

  • 1. Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine.
    Link S; Paulus W; Bandelow B
    Mov Disord; 2009 Dec; 24(16):2431-2. PubMed ID: 19890998
    [No Abstract]   [Full Text] [Related]  

  • 2. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease.
    Prueter C; Habermeyer B; Norra C; Kosinski CM
    Mov Disord; 2003 Jun; 18(6):712-3. PubMed ID: 12784279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
    Stephani C; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease.
    Baron MS; Dalton WB
    Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933
    [No Abstract]   [Full Text] [Related]  

  • 5. New Rx for psychoses in Alzheimer's, Parkinson's.
    Targum SD
    Contemp Longterm Care; 2001 Jan; 24(1):39-40. PubMed ID: 11209286
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
    Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
    J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
    Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
    Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations on the drug treatment of psychosis in Parkinson's disease.
    Friedman JH
    Am J Med; 2010 Apr; 123(4):e19; author reply e21. PubMed ID: 20362738
    [No Abstract]   [Full Text] [Related]  

  • 13. Quetiapine: novel uses in the treatment of depressive and anxiety disorders.
    Ravindran AV; Al-Subaie A; Abraham G
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chorea following withdrawal of quetiapine].
    Jiménez-Caballero PE; Velázquez-Pérez JM; Marsal-Alonso C; Alvarez-Tejerina A
    Rev Neurol; 2004 Jun 1-15; 38(11):1094. PubMed ID: 15202092
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
    López del Val LJ; Santos S
    Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D; Balas M; Peretz C; Shabtai H; Giladi N
    Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
    Kohmoto J; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
    Morgante L; Epifanio A; Spina E; Di Rosa AE; Zappia M; Basile G; La Spina P; Quattrone A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.